Singapore markets close in 1 hour 50 minutes

Heron Therapeutics, Inc. (HRTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
10.54+0.37 (+3.64%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
83,031
88,638
145,968
77,474
30,767
Cost of revenue
40,291
36,189
61,619
27,512
4,588
Gross profit
42,740
52,449
84,349
49,962
26,179
Operating expenses
Research development
166,984
174,533
167,382
140,032
138,582
Selling general and administrative
108,019
106,079
127,661
93,867
82,155
Total operating expenses
275,003
280,612
295,043
233,899
220,737
Operating income or loss
-232,263
-228,163
-210,694
-183,937
-194,558
Interest expense
-
1,901
1,472
2,672
3,937
Total other income/expenses net
-3,607
-847
158
1,804
-38
Income before tax
-234,138
-227,278
-204,749
-178,840
-197,484
Income from continuing operations
-234,138
-227,278
-204,749
-178,840
-197,484
Net income
-234,138
-227,278
-204,749
-178,840
-197,484
Net income available to common shareholders
-234,138
-227,278
-204,749
-178,840
-197,484
Basic EPS
-
-2.50
-2.50
-2.44
-3.65
Diluted EPS
-
-2.50
-2.50
-2.44
-3.65
Basic average shares
-
90,774
81,779
73,193
54,040
Diluted average shares
-
90,774
81,779
73,193
54,040
EBITDA
-
-222,530
-201,233
-174,655
-192,016